P142 Subcutaneously administered golimumab induction therapy improves health states measured by EQ-5D in patients with moderately to severely active ulcerative colitis: results from PURSUIT-SC

✍ Scribed by Gibson, P.; Feagan, B.; Marano, C.; Strauss, R.; Han, C.; Johanns, J.; Zhang, H.; Guzzo, C.; Colombel, J.-F.; Reinisch, W.; Collins, J.; Jarnerot, G.; Rutgeerts, P.; Sandborn, W.

• Book ID: 123379711
• Publisher: Oxford University Press
• Year: 2013
• Tongue: English
• Weight: 52 KB
• Volume: 7
• Category: Article
• ISSN: 1873-9946
• DOI: 10.1016/S1873-9946(13)60164-6